OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.21BP/E –Yield –
OPKO Health cash
Cash and short-term investments held at the end of each period.
OPKO Health's cash was $300.76M at Jun 30, 2026. For fiscal 2025 it was $364.41M, down 14.6% from the year before. Over ten years it grew 6.5% a year on average. The highest annual figure on record is $426.58M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $364.41M | -14.6% |
| FY2024 | Dec 31, 2024 | $426.58M | +344.9% |
| FY2023 | Dec 31, 2023 | $95.88M | -37.4% |
| FY2022 | Dec 31, 2022 | $153.19M | +13.7% |
| FY2021 | Dec 31, 2021 | $134.71M | +86.6% |
| FY2020 | Dec 31, 2020 | $72.21M | -15.5% |
| FY2019 | Dec 31, 2019 | $85.45M | -11.4% |
| FY2018 | Dec 31, 2018 | $96.47M | +5.4% |
| FY2017 | Dec 31, 2017 | $91.50M | -45.8% |
| FY2016 | Dec 31, 2016 | $168.73M | -12.8% |
| FY2015 | Dec 31, 2015 | $193.60M | +99.8% |
| FY2014 | Dec 31, 2014 | $96.91M | -47.8% |
| FY2013 | Dec 31, 2013 | $185.80M | +579.1% |
| FY2012 | Dec 31, 2012 | $27.36M | -61.7% |
| FY2011 | Dec 31, 2011 | $71.52M | +297.0% |
| FY2010 | Dec 31, 2010 | $18.02M | -57.8% |
| FY2009 | Dec 31, 2009 | $42.66M | +538.8% |
| FY2008 | Dec 31, 2008 | $6.68M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $300.76M | +12.5% |
| Q1 FY2026 | Mar 31, 2026 | $331.86M | -22.6% |
| Q4 FY2025 | Dec 31, 2025 | $364.41M | -14.6% |
| Q3 FY2025 | Sep 30, 2025 | $411.97M | +3.0% |
| Q2 FY2025 | Jun 30, 2025 | $267.28M | +558.7% |
| Q1 FY2025 | Mar 31, 2025 | $428.83M | +466.9% |
| Q4 FY2024 | Dec 31, 2024 | $426.58M | +344.9% |
| Q3 FY2024 | Sep 30, 2024 | $400.08M | +188.6% |
| Q2 FY2024 | Jun 30, 2024 | $40.58M | -62.5% |
| Q1 FY2024 | Mar 31, 2024 | $75.64M | -31.8% |
| Q4 FY2023 | Dec 31, 2023 | $95.88M | -37.4% |
| Q3 FY2023 | Sep 30, 2023 | $138.62M | -23.3% |
| Q2 FY2023 | Jun 30, 2023 | $108.11M | -48.6% |
| Q1 FY2023 | Mar 31, 2023 | $110.83M | +8.4% |
| Q4 FY2022 | Dec 31, 2022 | $153.19M | +13.7% |
| Q3 FY2022 | Sep 30, 2022 | $180.84M | +21.7% |
| Q2 FY2022 | Jun 30, 2022 | $210.46M | +220.1% |
| Q1 FY2022 | Mar 31, 2022 | $102.28M | +14.3% |
| Q4 FY2021 | Dec 31, 2021 | $134.71M | +86.6% |
| Q3 FY2021 | Sep 30, 2021 | $148.60M | +309.4% |
| Q2 FY2021 | Jun 30, 2021 | $65.76M | +204.3% |
| Q1 FY2021 | Mar 31, 2021 | $89.50M | +159.2% |
| Q4 FY2020 | Dec 31, 2020 | $72.21M | -15.5% |
| Q3 FY2020 | Sep 30, 2020 | $36.29M | -43.9% |
| Q2 FY2020 | Jun 30, 2020 | $21.61M | -80.5% |
| Q1 FY2020 | Mar 31, 2020 | $34.53M | -83.3% |
| Q4 FY2019 | Dec 31, 2019 | $85.45M | -11.4% |
| Q3 FY2019 | Sep 30, 2019 | $64.67M | +47.9% |
| Q2 FY2019 | Jun 30, 2019 | $111.12M | +38.2% |
| Q1 FY2019 | Mar 31, 2019 | $207.25M | +107.4% |
| Q4 FY2018 | Dec 31, 2018 | $96.47M | +5.4% |
| Q3 FY2018 | Sep 30, 2018 | $43.72M | -56.4% |
| Q2 FY2018 | Jun 30, 2018 | $80.38M | -38.4% |
| Q1 FY2018 | Mar 31, 2018 | $99.94M | -23.7% |
| Q4 FY2017 | Dec 31, 2017 | $91.50M | -45.8% |
| Q3 FY2017 | Sep 30, 2017 | $100.36M | -30.6% |
| Q2 FY2017 | Jun 30, 2017 | $130.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $131.05M | – |
| Q4 FY2016 | Dec 31, 2016 | $168.73M | – |
| Q3 FY2016 | Sep 30, 2016 | $144.65M | – |
See a number that looks wrong?